GlassScriptPhysician profile
Julie A Moore
NPI 1770511982
$902.15
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $160 · 2021: $139 · 2022: $12.84 · 2023: $59.72 · 2024: $13.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $188.33 | 2019-2021 | |
| Abbvie INC. | $185.91 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $67.45 | 2020 | |
| Hologic Sales and Service, LLC | $60.87 | 2019-2024 | Novasure |
| Pfizer INC. | $57.49 | 2019-2020 | |
| Allergan, INC. | $47.60 | 2019 | |
| Coopersurgical, INC. | $42.14 | 2019-2023 | Paragard T 380a |
| Exeltis, USA INC. | $41.71 | 2019 | |
| Avion Pharmaceuticals | $41.66 | 2019-2020 | |
| Medtronic, INC. | $38.31 | 2021 | |
| Amag Pharmaceuticals, INC. | $25.30 | 2019 | |
| Vertical Pharmaceuticals, LLC | $24.73 | 2019 | |
| Lupin INC. | $24.37 | 2019 | |
| Organon LLC | $16.57 | 2023 | Nexplanon |
| Evofem Biosciences, INC. | $14.51 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $13.00 | 2019 | |
| Therapeuticsmd, INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.